Inventor

KOZLOWSKI JOSEPH A

US85 patents

⚠️ This page may combine multiple inventors who share the name “KOZLOWSKI JOSEPH A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KOZLOWSKI JOSEPH A

SCHERING CORP

Muscarinic antagonists

Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity

Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity

Muscarinic antagonists

Muscarinic antagonists

Muscarinic antagonists

Muscarinic antagonists

Cannabinoid receptor ligands

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Benzimidazole derivatives useful as histamine H3 antagonists

2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity

Cannabinoid receptor ligands

Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity

Substituted heterocyclic compounds with CXCR3 antagonist activity

Compounds for the treatment of inflammatory disorders

Cannabinoid receptor ligands

Cannabinoid receptor agonists

Cannabinoid receptor ligands

Cannabinoid receptor ligands

Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity

Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity

Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity

Heterocyclic substituted pyridine compounds with CXCR3 antagonist activity

Compounds for the treatment of inflammatory disorders

Indolyl-, pyrrolyl- and pyrazolyl substituted benzazepines

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Heterocyclic substituted pyridine compounds with CXCR3 antagonist activity

Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity

Heterocyclic substituted piperazines with CXCR3 antagonist activity

Cannabinoid receptor ligands

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

MERCK SHARP & DOHME

Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases

Azabicyclo[4.1.0]heptane allosteric modulators of the M4 muscarinic acetylcholine receptor

Inhibitors of IRAK4 activity

ANILKUMAR GOPINADHAN N

2,3-substituted azaindole derivatives for treating viral infections

4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections

CHEN KEVIN X

4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections

Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C

LAVEY BRIAN J

Compounds for the treatment of inflammatory disorders

TONG LING

Compounds for the treatment of inflammatory disorders

COBURN CRAIG A

Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases

ROSENBLUM STUART B

Fused tricyclic aryl compounds useful for the treatment of viral diseases

KIM SEONG HEON

Heterocyclic substituted piperazines with CXCR3 antagonist activity

ZENG QINGBEI

Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C

NAIR ANILKUMAR GOPINADHAN

Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases